U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
National Eye Institute (NEI) <http://www.nei.nih.gov/>
For Immediate Release: Thursday, April 28, 2011
CONTACT: National Eye Institute, 301-496-5248, <e-mail:neinews@xxxxxxxxxxx>
MEDIA ADVISORY
NEI ANNOUNCES THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIAL (CATT) STUDY RESULTS COMPARING THE EFFICACY OF AVASTIN AND LUCENTIS
Media Telebriefing: Thursday, April 28, 2:00 pm EDT
WHAT:
The Comparison of AMD Treatments Trial (CATT) studied two treatment options - Lucentis and Avastin - for patients with age-related macular degeneration (AMD). Four treatment groups were evaluated: Lucentis given monthly, Lucentis given as needed, Avastin given monthly and Avastin given as needed. The study's first year results will be reported to the press at this telebriefing.
The study was funded by the National Eye Institute (NEI) of the National Institutes of Health (NIH), and will be published online in the New England Journal of Medicine on Thursday, April 28, 2011. The results will be announced by the NEI and the study chair. Speakers will deliver brief remarks, followed by a question and answer session with the media.
WHEN:
Thursday, April 28, 2011 2:00 pm EDT
WHO:
Paul A. Sieving, M.D., Ph.D., Director of the National Eye Institute
Daniel F. Martin, M.D., Study Chair for CATT, and Chairman of the Cole Eye Institute at the Cleveland Clinic Maureen G. Maguire, Ph.D., Director of CATT Coordinating Center and
Carolyn F. Jones Professor of Ophthalmology, University of Pennsylvania
WHERE:
Teleconference Service: InterCall
Dial-in Number: 1-866-394-5647
Conference ID: 62262856
Teleconference Name: National Eye Institute, CATT Study Results
The teleconference is open to members of the press only. The briefing will begin promptly at 2:00 pm EDT. To participate, please dial in 10 minutes prior to that time to the dial-in number above, followed by the Conference ID number at the prompt. Dialing in 15 minutes early will better ensure access to the limited number of phone lines available. A rebroadcast will be available for 24 hours after the briefing at: 1-800-642-1687; Access Code: 62262856. Transcripts will be available later today.
CONTACT:
For additional information contact the NEI Communications Office at:
301-496-5248 or <E-MAIL:neinews@xxxxxxxxxxx>.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <www.nih.gov>.
##
To subscribe (or unsubscribe) from NIH News Release mailings, go to
<http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
If you subscribed via the NIH Listserv, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.
